INTERVIEW | How an unassuming acquisition is putting Aspen on the map as a Covid-19 vaccine manufacturer | Fin24 - Find all the latest news, Breaking News, Top Headlines about Africa | Africantimes

Breaking

Post Top Ad

Post Top Ad

Monday, 22 March 2021

INTERVIEW | How an unassuming acquisition is putting Aspen on the map as a Covid-19 vaccine manufacturer | Fin24

In 24 years, Aspen Pharmacare has grown into a company valued at more than R67 billion, but a package deal on an acquisition it made in its early days has put it on the map.


from Fin24: Business & Finance News, Stock Markets & Investing
Read The Rest:fin24...

No comments:

Post a comment

Post Top Ad